Latest News & Developments
share price
Sasol share price slumps amid operational challenges and global market pressures
Discover how a series of operational setbacks and global market dynamics have led to a staggering decline in Sasol's share price, as analysts weigh the potential for recovery amid ongoing challenges in the fuel and chemicals sectors.
Raubex Group predicts solid earnings growth amid new contracts including Parliament repair
Raubex Group's share price rose over 8% on the JSE following a positive earnings forecast, with significant new contracts, including a R1. 98 billion project to upgrade the Parliament buildings in Cape Town
Momentum Group leads the pack after all its businesses report strong interim growth
Momentum Group's share price surged over 10% following a remarkable 44% increase in normalised headline earnings to R3. 4 billion for the six months ending December 31, showcasing strong performance across all business units.
African Rainbow Capital Investments plans to delist from JSE and A2X markets
African Rainbow Capital Investments intends to delist from the JSE and A2X markets, offering shareholders a premium for their shares while shifting its headquarters to South Africa due to limited international investment.
Renergen's share price soars 37% following liquid helium milestone
Renergen's share price surged 37. 3% after successfully filling a container with liquid helium, marking a significant milestone in the development of South Africa's first onshore liquid natural gas and helium production facility
Exxaro Resources reports decline in headline earnings per share amid lower iron ore prices
Exxaro Resources anticipates a significant decline in headline earnings per share due to lower iron ore prices and increased operational costs, as the company faces leadership changes and market challenges.
Grindrod cuts dividend by 55% due to border disruptions, lower commodity prices
Despite challenges, Grindrod's CEO highlights growth opportunities in logistics infrastructure as the company navigates a tough market
Aspen Pharmacare's strong interim earnings boosts the share price by 10. 6%
Aspen Pharmacare's share price surged by 10. 6% following robust financial results for the first half of the 2025 financial year, driven by strong performances in Commercial Pharmaceuticals and Manufacturing